Scientific research has identified a link between Tylenol (acetaminophen) use during pregnancy and neurodevelopmental disorders like autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children. This discovery has sparked hundreds of lawsuits against manufacturers and retailers, with cases now moving through federal courts and state systems across the country. What Does the Scientific Evidence Show? The legal claims rest on multiple peer-reviewed epidemiological studiesâresearch that tracks health outcomes across large populationsâshowing a connection between prenatal acetaminophen exposure and neurodevelopmental conditions. However, the scientific community remains divided on the strength of this evidence. In January 2026, a study published in The Lancet found no link between Tylenol and autism, but experts including Dr. Jay Bhattacharya, Director of the National Institutes of Health, criticized the research methodology. "Critics argued that while the study used sibling controlsâwhich are generally strong at reducing genetic confoundingâthey have inherent weaknesses," particularly because families with discordant siblings (where one child was exposed and another was not) may not represent the general population and might "wash out" real effects. Dr. Andrea Baccarelli from Harvard School of Public Health maintained that concerns about acetaminophen use during pregnancy remain valid despite the new findings. How Large Is the Tylenol Autism Litigation? The legal action is substantial. Hundreds of federal lawsuits have been consolidated into a Multidistrict Litigation (MDL) caseâa legal process that combines similar claims for coordinated handlingâdesignated as MDL No. 3043 in the Southern District of New York under Judge Denise Cote. The litigation targets Johnson & Johnson, Kenvue (a spinoff company that now markets Tylenol), and major retailers including Walmart, CVS, Walgreens, Costco, and Rite Aid. The cases involve children diagnosed with autism spectrum disorder or ADHD after in-utero acetaminophen exposure. Plaintiffs argue that manufacturers and retailers failed to warn pregnant women about potential risks despite awareness of scientific literature linking the drug to these conditions. What Are the Potential Settlement Amounts? Settlement ranges vary significantly based on autism severity levels, reflecting the different impacts on families: - Level 1 (Mild Autism): Estimated settlements between $50,000 and $225,000 for cases involving minimal functional impairment. - Level 2 (Moderate Autism): Estimated settlements between $225,000 and $500,000 for cases with moderate support needs. - Level 3 (Severe Autism): Settlements exceeding $500,000, with potential for multi-million-dollar outcomes for children requiring substantial daily support. - Jury Verdicts: Severe autism spectrum disorder cases could result in jury verdicts exceeding $2 million. What's the Current Status of the Legal Cases? The litigation has faced significant procedural hurdles. In December 2023, Judge Cote excluded all five plaintiff expert witnesses, which led to dismissal of the MDL on grounds that causation evidence was unreliable. However, in February 2024, the judge allowed a new expert report from certain plaintiffs, and additional hearings were scheduled. As of mid-2025, appeals were pending in the Second Circuit Court of Appeals regarding the expert exclusion decisionâa pivotal moment that will determine whether the MDL can proceed. Recent developments show momentum building in state courts. In March 2026, new lawsuits began appearing in Illinois, Florida, and Pennsylvania dockets, suggesting that if federal litigation stalls, cases may move to state systems. In February 2026, a Texas judge rejected Kenvue and Johnson & Johnson's attempt to dismiss a lawsuit filed by Texas Attorney General Ken Paxton, which alleges the companies violated deceptive trade practices laws by marketing Tylenol as the safest pain reliever for pregnant women while being aware of 26 epidemiological studies linking acetaminophen to autism. Steps to Take If Your Child Was Exposed to Tylenol During Pregnancy - Document Medical History: Gather records showing acetaminophen use during pregnancy and your child's subsequent autism or ADHD diagnosis, including dates and dosages if available. - Consult a Specialized Attorney: Contact lawyers experienced in Tylenol litigation who can evaluate whether your case meets the criteria for joining existing lawsuits or MDL proceedings. - Understand Your Timeline: Be aware that appeal decisions and expert rulings will determine case progression, so legal representation can help you navigate changing timelines and settlement opportunities. - Explore Multiple Venues: If federal litigation appears stalled, discuss with your attorney whether filing in state court might be advantageous for your family's situation. What Should Pregnant Women Know Now? Health professionals advise pregnant women to avoid taking any medication or supplements during pregnancy without first consulting their doctors. Until recently, acetaminophen was widely considered safe for use during pregnancy, but the emerging scientific evidence and ongoing litigation have raised questions about this assumption. The debate between recent studies finding no link and the body of epidemiological research suggesting a connection means the scientific community has not reached consensus. Pregnant women experiencing pain or fever should discuss all optionsâincluding non-medication approaches and alternative treatmentsâwith their healthcare providers before taking any over-the-counter medication. The litigation process will likely take years to resolve, but families who believe their children were harmed by prenatal acetaminophen exposure have legal options to pursue compensation.
